Duration of challenge immunity to coronavirus JHM in mice
Identifieur interne : 001C45 ( Main/Exploration ); précédent : 001C44; suivant : 001C46Duration of challenge immunity to coronavirus JHM in mice
Auteurs : S. W. Barthold [États-Unis] ; Abigail L. Smith [États-Unis]Source :
- Archives of Virology [ 0304-8608 ] ; 1989-09-01.
Descripteurs français
- KwdFr :
- Animaux, Anticorps antiviraux (analyse), Attribution aléatoire, Facteurs temps, Foie (anatomopathologie), Foie (microbiologie), Immunité, Intestins (anatomopathologie), Intestins (immunologie), Os nasal (microbiologie), Souris, Souris de lignée BALB C, Tissu lymphoïde (anatomopathologie), Virus de l'hépatite murine (immunologie), Virus de l'hépatite murine (isolement et purification).
- MESH :
- analyse : Anticorps antiviraux.
- anatomopathologie : Foie, Intestins, Tissu lymphoïde.
- immunologie : Intestins, Virus de l'hépatite murine.
- isolement et purification : Virus de l'hépatite murine.
- microbiologie : Foie, Os nasal.
- Pascal (Inist)
- Appareil respiratoire pathologie, Coronavirus murin, Etude comparative, Immunisation, Immunité, Modèle animal, Multiplication virus, Réinfection, Réponse immune, Résistance, Sensibilité, Souche, Souris, Souris BALB/c, Tissu lymphoïde associé intestin, Virose, Virus hépatite murine, Voie administration.
- MESH :
English descriptors
- KwdEn :
- Animal model, Animals, Antibodies, Viral (analysis), Comparative study, Immune response, Immunity, Immunization, Intestines (immunology), Intestines (pathology), Liver (microbiology), Liver (pathology), Lymphoid Tissue (pathology), Mice, Mice, Inbred BALB C, Mouse, Murine coronavirus, Murine hepatitis virus, Murine hepatitis virus (immunology), Murine hepatitis virus (isolation & purification), Nasal Bone (microbiology), Random Allocation, Reinfection, Resistance, Respiratory disease, Route of administration, Sensitivity, Strain, Time Factors, Viral disease, Virus multiplication.
- MESH :
- chemical , analysis : Antibodies, Viral.
- immunology : Intestines, Murine hepatitis virus.
- isolation & purification : Murine hepatitis virus.
- microbiology : Liver, Nasal Bone.
- pathology : Intestines, Liver, Lymphoid Tissue.
- Teeft :
- Absolute challenge resistance, Animals, Antibody titers, Arch virol, Barthold, Brain infection, Challenge immunity, Challenge infection, Challenge resistance, Comparative medicine, Coronavirus, Detectable liver virus, Detectable virus, Experimental mice, Galt, High prevalence, High titers, Immunity, Immunization, Immunizing infection, Infection, Inoculation, Inoculation results, Intranasal, Intranasal challenge inoculation, Intranasal inoculation, Lesion, Lymphoid tissue, Mice, Mice, Inbred BALB C, Month interval, Mouse, Mouse hepatitis virus, Nasal, Nasal mucosa, Nasal turbinates, Olfactory mucosa, Random Allocation, Rodent coronaviruses, Same coronavirus strain, Sentinel mice, Serum antibody, Sham, Sham inoculation, Shamimmunized mice, Sterile tissue culture fluid, Susceptible mice, Time Factors, Tissue culture fluid, Titer, Treatment groups, Turbinate, Virus strainspecific, Yale university school.
Abstract
Summary: The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalance of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.
Url:
- https://api.istex.fr/ark:/67375/1BB-4BD0PJDZ-W/fulltext.pdf
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087252
DOI: 10.1007/BF01317914
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000176
- to stream Istex, to step Curation: 000144
- to stream Istex, to step Checkpoint: 000622
- to stream Pmc, to step Corpus: 000183
- to stream Pmc, to step Curation: 000183
- to stream Pmc, to step Checkpoint: 000A77
- to stream PubMed, to step Corpus: 000D99
- to stream PubMed, to step Curation: 000D99
- to stream PubMed, to step Checkpoint: 000D78
- to stream Ncbi, to step Merge: 000484
- to stream Ncbi, to step Curation: 000484
- to stream Ncbi, to step Checkpoint: 000484
- to stream Main, to step Merge: 001C65
- to stream PascalFrancis, to step Corpus: 000068
- to stream PascalFrancis, to step Curation: 000062
- to stream PascalFrancis, to step Checkpoint: 000067
- to stream Main, to step Merge: 001C72
- to stream Main, to step Curation: 001C45
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Duration of challenge immunity to coronavirus JHM in mice</title>
<author><name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S. W." last="Barthold">S. W. Barthold</name>
</author>
<author><name sortKey="Smith, Abigail L" sort="Smith, Abigail L" uniqKey="Smith A" first="Abigail L." last="Smith">Abigail L. Smith</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0A92D565FBC57699E16D52F3EC7499CD1AFA1349</idno>
<date when="1989" year="1989">1989</date>
<idno type="doi">10.1007/BF01317914</idno>
<idno type="url">https://api.istex.fr/ark:/67375/1BB-4BD0PJDZ-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000176</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000176</idno>
<idno type="wicri:Area/Istex/Curation">000144</idno>
<idno type="wicri:Area/Istex/Checkpoint">000622</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000622</idno>
<idno type="wicri:doubleKey">0304-8608:1989:Barthold S:duration:of:challenge</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087252</idno>
<idno type="RBID">PMC:7087252</idno>
<idno type="wicri:Area/Pmc/Corpus">000183</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000183</idno>
<idno type="wicri:Area/Pmc/Curation">000183</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000183</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000A77</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000A77</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:2554852</idno>
<idno type="wicri:Area/PubMed/Corpus">000D99</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D99</idno>
<idno type="wicri:Area/PubMed/Curation">000D99</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D99</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000D78</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D78</idno>
<idno type="wicri:Area/Ncbi/Merge">000484</idno>
<idno type="wicri:Area/Ncbi/Curation">000484</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000484</idno>
<idno type="wicri:doubleKey">0304-8608:1989:Barthold S:duration:of:challenge</idno>
<idno type="wicri:Area/Main/Merge">001C65</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:90-0072389</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000068</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000062</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000067</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000067</idno>
<idno type="wicri:doubleKey">0304-8608:1989:Barthold S:duration:of:challenge</idno>
<idno type="wicri:Area/Main/Merge">001C72</idno>
<idno type="wicri:Area/Main/Curation">001C45</idno>
<idno type="wicri:Area/Main/Exploration">001C45</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Duration of challenge immunity to coronavirus JHM in mice</title>
<author><name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S. W." last="Barthold">S. W. Barthold</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of Compariative Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Smith, Abigail L" sort="Smith, Abigail L" uniqKey="Smith A" first="Abigail L." last="Smith">Abigail L. Smith</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of Compariative Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Archives of Virology</title>
<title level="j" type="abbrev">Archives of Virology</title>
<idno type="ISSN">0304-8608</idno>
<idno type="eISSN">1432-8798</idno>
<imprint><publisher>Springer-Verlag</publisher>
<pubPlace>Vienna</pubPlace>
<date type="published" when="1989-09-01">1989-09-01</date>
<biblScope unit="volume">107</biblScope>
<biblScope unit="issue">3-4</biblScope>
<biblScope unit="page" from="171">171</biblScope>
<biblScope unit="page" to="177">177</biblScope>
</imprint>
<idno type="ISSN">0304-8608</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0304-8608</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal model</term>
<term>Animals</term>
<term>Antibodies, Viral (analysis)</term>
<term>Comparative study</term>
<term>Immune response</term>
<term>Immunity</term>
<term>Immunization</term>
<term>Intestines (immunology)</term>
<term>Intestines (pathology)</term>
<term>Liver (microbiology)</term>
<term>Liver (pathology)</term>
<term>Lymphoid Tissue (pathology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mouse</term>
<term>Murine coronavirus</term>
<term>Murine hepatitis virus</term>
<term>Murine hepatitis virus (immunology)</term>
<term>Murine hepatitis virus (isolation & purification)</term>
<term>Nasal Bone (microbiology)</term>
<term>Random Allocation</term>
<term>Reinfection</term>
<term>Resistance</term>
<term>Respiratory disease</term>
<term>Route of administration</term>
<term>Sensitivity</term>
<term>Strain</term>
<term>Time Factors</term>
<term>Viral disease</term>
<term>Virus multiplication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps antiviraux (analyse)</term>
<term>Attribution aléatoire</term>
<term>Facteurs temps</term>
<term>Foie (anatomopathologie)</term>
<term>Foie (microbiologie)</term>
<term>Immunité</term>
<term>Intestins (anatomopathologie)</term>
<term>Intestins (immunologie)</term>
<term>Os nasal (microbiologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Tissu lymphoïde (anatomopathologie)</term>
<term>Virus de l'hépatite murine (immunologie)</term>
<term>Virus de l'hépatite murine (isolement et purification)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Foie</term>
<term>Intestins</term>
<term>Tissu lymphoïde</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Intestins</term>
<term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Intestines</term>
<term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Murine hepatitis virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus de l'hépatite murine</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Foie</term>
<term>Os nasal</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Liver</term>
<term>Nasal Bone</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Intestines</term>
<term>Liver</term>
<term>Lymphoid Tissue</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Appareil respiratoire pathologie</term>
<term>Coronavirus murin</term>
<term>Etude comparative</term>
<term>Immunisation</term>
<term>Immunité</term>
<term>Modèle animal</term>
<term>Multiplication virus</term>
<term>Réinfection</term>
<term>Réponse immune</term>
<term>Résistance</term>
<term>Sensibilité</term>
<term>Souche</term>
<term>Souris</term>
<term>Souris BALB/c</term>
<term>Tissu lymphoïde associé intestin</term>
<term>Virose</term>
<term>Virus hépatite murine</term>
<term>Voie administration</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Absolute challenge resistance</term>
<term>Animals</term>
<term>Antibody titers</term>
<term>Arch virol</term>
<term>Barthold</term>
<term>Brain infection</term>
<term>Challenge immunity</term>
<term>Challenge infection</term>
<term>Challenge resistance</term>
<term>Comparative medicine</term>
<term>Coronavirus</term>
<term>Detectable liver virus</term>
<term>Detectable virus</term>
<term>Experimental mice</term>
<term>Galt</term>
<term>High prevalence</term>
<term>High titers</term>
<term>Immunity</term>
<term>Immunization</term>
<term>Immunizing infection</term>
<term>Infection</term>
<term>Inoculation</term>
<term>Inoculation results</term>
<term>Intranasal</term>
<term>Intranasal challenge inoculation</term>
<term>Intranasal inoculation</term>
<term>Lesion</term>
<term>Lymphoid tissue</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Month interval</term>
<term>Mouse</term>
<term>Mouse hepatitis virus</term>
<term>Nasal</term>
<term>Nasal mucosa</term>
<term>Nasal turbinates</term>
<term>Olfactory mucosa</term>
<term>Random Allocation</term>
<term>Rodent coronaviruses</term>
<term>Same coronavirus strain</term>
<term>Sentinel mice</term>
<term>Serum antibody</term>
<term>Sham</term>
<term>Sham inoculation</term>
<term>Shamimmunized mice</term>
<term>Sterile tissue culture fluid</term>
<term>Susceptible mice</term>
<term>Time Factors</term>
<term>Tissue culture fluid</term>
<term>Titer</term>
<term>Treatment groups</term>
<term>Turbinate</term>
<term>Virus strainspecific</term>
<term>Yale university school</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Attribution aléatoire</term>
<term>Facteurs temps</term>
<term>Immunité</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Summary: The duration of challenge resistance in mice immunized with mouse hepatitis virus (MHV) strain JHM was examined as a model of immunity to corona-virus infection. Genetically susceptible BALB/cByJ mice were immunized by intranasal (i.n.) or per os (p.o.) inoculation with MHV-JHM or sterile tissue culture fluid (sham) then challenged i.n. with MHV-JHM or sterile tissue culture fluid 1, 6, or 12 months later. Four days after challenge, virus in nasal turbinates and liver was quantified, and prevalance of microscopic lesions in liver and gut-associated lymphoid tissue was tabulated as indices of challenge resistance. MHV-immunized and challenged groups were compared to sham-immunized and challenged groups. Mice immunized by i.n. inoculation were strongly resistant to challenge at 1, 6, and 12 months. Mice immunized by p.o. inoculation were resistant at 1 month, but became partially susceptible to reinfection at 6 and 12 months, based upon all indices. These data indicate that, depending upon route of immunization, mice can become susceptible to reinfection with the same coronavirus strain over time.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Connecticut</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Barthold, S W" sort="Barthold, S W" uniqKey="Barthold S" first="S. W." last="Barthold">S. W. Barthold</name>
</region>
<name sortKey="Smith, Abigail L" sort="Smith, Abigail L" uniqKey="Smith A" first="Abigail L." last="Smith">Abigail L. Smith</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:0A92D565FBC57699E16D52F3EC7499CD1AFA1349 |texte= Duration of challenge immunity to coronavirus JHM in mice }}
This area was generated with Dilib version V0.6.33. |